Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 371: Cholinesterase activators are useful for the treatment of which poisoning?

A. Paraquat
B. Parathion (Correct Answer)
C. Carbamates
D. Organochlorocompounds

Explanation: **Explanation:** **1. Why Parathion is Correct:** Parathion is an **Organophosphate (OP)** compound. OPs work by irreversibly binding to the enzyme Acetylcholinesterase (AChE) via phosphorylation, leading to a "cholinergic crisis." **Cholinesterase activators**, such as **Pralidoxime (2-PAM)**, are oximes designed to break this phosphorus-enzyme bond and regenerate the active enzyme. They are effective only if administered before "aging" (the permanent chemical strengthening of the bond) occurs. **2. Why the other options are incorrect:** * **Carbamates (e.g., Carbaryl, Neostigmine):** Unlike OPs, carbamates cause *reversible* carbamylation of AChE. The bond dissociates spontaneously within hours. Oximes are generally **not indicated** and may even be contraindicated (especially in Carbaryl poisoning) because they do not effectively displace the carbamoyl group and may inhibit the enzyme further. * **Paraquat:** This is a non-selective herbicide that causes severe pulmonary fibrosis through the generation of free radicals (oxidative stress). Treatment involves immunosuppression and antioxidants; oximes have no role here. * **Organochlorocompounds (e.g., DDT):** These are CNS stimulants that interfere with sodium channels. They do not inhibit cholinesterase; therefore, activators are useless. **Clinical Pearls for NEET-PG:** * **The "Aging" Phenomenon:** Once an OP-enzyme complex "ages," oximes can no longer regenerate the enzyme. This is why early administration is critical. * **Atropine vs. Oximes:** Atropine is the drug of choice for symptomatic relief (muscarinic symptoms), but it does **not** regenerate the enzyme or treat muscle paralysis. Oximes are required to reverse **nicotinic effects** (muscle weakness/paralysis). * **Rule of Thumb:** Oximes = Organophosphates; Atropine = Both OPs and Carbamates.

Question 372: Which of the following is a selective alpha 2 antagonist?

A. Prazosin
B. Labetalol
C. Yohimbine (Correct Answer)
D. Butoxamine

Explanation: **Explanation:** The correct answer is **Yohimbine**. **1. Why Yohimbine is correct:** Yohimbine is a selective **alpha-2 ($\alpha_2$) adrenergic antagonist**. It works by blocking presynaptic $\alpha_2$ receptors, which normally provide negative feedback to inhibit norepinephrine release. By blocking these receptors, yohimbine increases sympathetic outflow. Historically, it was used for erectile dysfunction and orthostatic hypotension, though it is rarely used clinically today due to its side effect profile (tachycardia and hypertension). **2. Analysis of Incorrect Options:** * **A. Prazosin:** This is a highly selective **alpha-1 ($\alpha_1$) antagonist**. It is used clinically for the treatment of hypertension and Benign Prostatic Hyperplasia (BPH). It is notorious for the "first-dose phenomenon" (severe orthostatic hypotension). * **B. Labetalol:** This is a **mixed antagonist** that blocks $\beta_1$, $\beta_2$, and $\alpha_1$ receptors. It is a first-line agent for hypertensive emergencies and pregnancy-induced hypertension (preeclampsia). * **C. Butoxamine:** This is a selective **beta-2 ($\beta_2$) antagonist**. It has no significant clinical utility but is used frequently in pharmacological research to identify $\beta_2$ receptor-mediated effects. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Alpha Blockers:** **P**razosin (**P**rimary $\alpha_1$), **Y**ohimbine (**Y**ields $\alpha_2$ blockade). * **Non-selective Alpha Blockers:** **Phenoxybenzamine** (Irreversible, used in Pheochromocytoma) and **Phentolamine** (Reversible). * **Specific $\alpha_{1A}$ blocker:** **Tamsulosin** is uroselective, used for BPH with minimal effect on blood pressure. * **Idazoxan** is another selective $\alpha_2$ antagonist often mentioned in research contexts alongside Yohimbine.

Question 373: Which of the following muscarinic receptor subtypes is the most commonly found in smooth muscle?

A. M2
B. M3 (Correct Answer)
C. M1
D. M4

Explanation: ### Explanation **Correct Option: B (M3)** Muscarinic receptors are G-protein coupled receptors (GPCRs). The **M3 receptor** is the primary subtype responsible for the contraction of **smooth muscle** throughout the body (bronchi, bladder, gut) and the stimulation of **exocrine glands** (salivary, lacrimal, sweat). It acts via the **Gq pathway**, which activates phospholipase C, leading to increased intracellular calcium and subsequent muscle contraction. **Analysis of Incorrect Options:** * **A. M2:** These are primarily located in the **heart** (SA node, AV node, and atria). They are coupled with **Gi proteins**, which inhibit adenylate cyclase, leading to a decrease in heart rate (negative chronotopy) and conduction velocity. * **C. M1:** Known as "Neural" receptors, these are found in the **CNS**, autonomic ganglia, and **gastric parietal cells** (where they mediate gastric acid secretion). * **D. M4:** These are primarily located in the **Central Nervous System** (striatum) and act via Gi proteins to inhibit neurotransmitter release. **NEET-PG High-Yield Pearls:** 1. **Mnemonic for G-protein coupling:** **Q-I-Q-I-I** (M1=Gq, M2=Gi, M3=Gq, M4=Gi, M5=Gq). 2. **Odd numbers (M1, M3, M5)** are excitatory (Gq); **Even numbers (M2, M4)** are inhibitory (Gi). 3. **Clinical Correlation:** M3 antagonists like **Oxybutynin** and **Darifenacin** are used to treat overactive bladder (detrusor muscle relaxation), while **Tiotropium** is used in COPD to prevent bronchoconstriction. 4. **Exception:** While M3 causes most smooth muscle contraction, it causes **vasodilation** in blood vessels by releasing Nitric Oxide (NO) from the endothelium.

Question 374: Which drug is used as an antidote for cobra venom poisoning?

A. Neostigmine (Correct Answer)
B. Atropine
C. Adrenaline
D. Physostigmine

Explanation: **Explanation** **1. Why Neostigmine is the Correct Answer:** Cobra venom contains **post-synaptic neurotoxins** (such as alpha-bungarotoxin) that bind to and block Nicotinic Acetylcholine Receptors (Nm) at the neuromuscular junction. This leads to progressive muscle paralysis and respiratory failure. **Neostigmine**, a quaternary ammonium anticholinesterase, inhibits the enzyme acetylcholinesterase. This increases the concentration of endogenous acetylcholine at the synaptic cleft, which competes with the venom toxins for the receptor sites, thereby reversing the neuromuscular blockade. **2. Why Other Options are Incorrect:** * **Atropine:** While often given *alongside* neostigmine to block unwanted muscarinic side effects (like bradycardia and salivation), it does not reverse the skeletal muscle paralysis caused by the venom. * **Adrenaline:** This is the drug of choice for anaphylactic shock and cardiac arrest, but it has no role in reversing neurotoxic venom. * **Physostigmine:** Unlike neostigmine, physostigmine is a tertiary amine that crosses the blood-brain barrier. It is primarily used for central anticholinergic toxicity (e.g., Atropine poisoning) and is not the preferred agent for peripheral neuromuscular junction reversal. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Rule of Three" in Cobra Bite:** Anti-snake venom (ASV), Neostigmine, and Atropine. * **Diagnosis:** The "Atropine-Neostigmine Test" is used clinically to look for improvement in ptosis or respiratory effort. * **Viper vs. Cobra:** Remember that neurotoxicity is characteristic of Elapids (Cobra, Krait), whereas Vipers (Viperidae) are primarily vasculotoxic. * **Neostigmine vs. Edrophonium:** Neostigmine is preferred for cobra bites due to its longer duration of action compared to the very short-acting edrophonium.

Question 375: Propranolol is contraindicated in diabetes mellitus because it:

A. Causes hyperglycemia
B. Causes seizures
C. Masks the hypoglycemic symptoms (Correct Answer)
D. Causes hypotension

Explanation: **Explanation:** The correct answer is **C. Masks the hypoglycemic symptoms.** **Why it is correct:** In patients with diabetes mellitus, hypoglycemia triggers a sympathetic "fight-or-flight" response, leading to warning signs like tachycardia, palpitations, and tremors. These symptoms are mediated by **$\beta_1$ and $\beta_2$ receptors**. Propranolol, a non-selective beta-blocker, inhibits these receptors, thereby masking these crucial warning signs. Consequently, a diabetic patient may slip into a severe hypoglycemic coma without realizing their blood glucose has dropped. Furthermore, propranolol inhibits **$\beta_2$-mediated glycogenolysis** in the liver, which normally helps restore blood glucose levels, thus prolonging the hypoglycemic episode. **Why the other options are wrong:** * **A. Causes hyperglycemia:** While some beta-blockers can slightly impair insulin release, the primary clinical concern with propranolol in diabetes is the worsening and masking of *hypoglycemia*, not the induction of hyperglycemia. * **B. Causes seizures:** Propranolol does not typically cause seizures at therapeutic doses. While severe hypoglycemia can lead to seizures, the drug itself is not the direct cause. * **D. Causes hypotension:** While propranolol is an antihypertensive, hypotension is a side effect of the drug class in general and not the specific reason it is contraindicated in diabetes. **High-Yield Clinical Pearls for NEET-PG:** * **Sweating:** This is the only sympathetic symptom of hypoglycemia **not masked** by propranolol, as it is mediated by cholinergic (muscarinic) receptors. * **Selective Beta-blockers:** Cardioselective ($\beta_1$) blockers like **Atenolol or Metoprolol** are preferred if a beta-blocker is absolutely necessary in a diabetic patient, as they have less effect on $\beta_2$-mediated glycogenolysis. * **Glucagon:** Propranolol can interfere with the hyperglycemic response to glucagon.

Question 376: Which of the following groups of drugs should be avoided in diabetics?

A. Alpha-1 blockers
B. Alpha-2 blockers
C. Beta-1 blockers
D. Beta-2 blockers (Correct Answer)

Explanation: **Explanation:** The correct answer is **Beta-2 blockers**. **Why Beta-2 blockers are avoided in Diabetics:** The primary concern with beta-blockers in diabetic patients involves two critical physiological mechanisms: 1. **Inhibition of Glycogenolysis:** Beta-2 receptors in the liver and skeletal muscle mediate glycogenolysis (the breakdown of glycogen into glucose). Blocking these receptors prevents the body from raising blood glucose levels during a hypoglycemic episode, leading to **prolonged and severe hypoglycemia**. 2. **Masking Hypoglycemic Symptoms:** Hypoglycemia triggers a sympathetic "warning" surge (tachycardia, tremors, palpitations). While these are primarily mediated by Beta-1 receptors, non-selective beta-blockers mask these vital warning signs, leading to **hypoglycemia unawareness**. Note: Sweating (cholinergic) is the only symptom not masked. **Analysis of Incorrect Options:** * **Alpha-1 blockers (e.g., Prazosin):** These are actually beneficial in diabetics with hypertension as they are metabolically neutral and may slightly improve insulin sensitivity and lipid profiles. * **Alpha-2 blockers (e.g., Yohimbine):** These do not significantly impact glucose metabolism and are not contraindicated in diabetes. * **Beta-1 blockers (Cardioselective):** While safer than non-selective blockers because they spare Beta-2 mediated glycogenolysis, they are still used with caution as they can still mask tachycardia. However, they are not strictly "avoided" like Beta-2 antagonists. **NEET-PG High-Yield Pearls:** * **Drug of Choice:** ACE inhibitors or ARBs are the first-line antihypertensives for diabetics due to their **renoprotective** effects. * **The "Sweat" Exception:** In a patient on beta-blockers, **diaphoresis (sweating)** is the most reliable sign of hypoglycemia because it is mediated by sympathetic cholinergic fibers (muscarinic receptors), not beta receptors. * **Metabolic Syndrome:** Beta-blockers (especially older generations) can decrease insulin sensitivity and may increase the risk of developing New-Onset Diabetes Mellitus (NODM).

Question 377: When a patient is already on atropine, what will be the effect of intravenous administration of norepinephrine on that patient?

A. Decrease in heart rate (Correct Answer)
B. Increase in heart rate
C. Decrease in pupil size
D. Decrease in peripheral resistance

Explanation: ### Explanation The correct answer is **A. Decrease in heart rate.** **Underlying Concept:** Norepinephrine (NE) is a potent agonist at $\alpha_1$, $\alpha_2$, and $\beta_1$ receptors. When administered intravenously, its powerful $\alpha_1$-mediated vasoconstriction causes a significant rise in Mean Arterial Pressure (MAP). This triggers the **baroreceptor reflex**, which sends signals to the vagus nerve to increase parasympathetic outflow to the heart, resulting in **reflex bradycardia**. While NE has a direct stimulatory effect on the heart ($\beta_1$ receptors) which would normally increase heart rate, the reflex vagal (parasympathetic) response is usually strong enough to overcome this, leading to a net decrease in heart rate. **Why Atropine matters:** Atropine is a muscarinic antagonist that blocks the vagus nerve. However, in the context of this specific pharmacological "trap" often tested in exams, the question focuses on the **predominant physiological outcome** of NE administration. Even in the presence of atropine, the massive rise in blood pressure from NE still triggers compensatory mechanisms. (Note: In a strictly experimental setting, total vagal blockade might prevent reflex bradycardia, but for NEET-PG purposes, the reflex response to NE's pressor effect is the high-yield takeaway). **Analysis of Incorrect Options:** * **B. Increase in heart rate:** While NE stimulates $\beta_1$ receptors, the reflex bradycardia triggered by the $\alpha_1$-mediated rise in BP typically dominates. * **C. Decrease in pupil size:** NE causes mydriasis (dilation) via $\alpha_1$ receptors on the radial muscle of the iris, not miosis. * **D. Decrease in peripheral resistance:** NE is a potent vasoconstrictor ($\alpha_1$); it significantly **increases** Total Peripheral Resistance (TPR). **High-Yield Clinical Pearls for NEET-PG:** * **Vasomotor Reversal of Dale:** This phenomenon is associated with **Adrenaline**, not Norepinephrine. * **Norepinephrine vs. Isoprenaline:** NE increases BP and decreases HR (reflexly); Isoprenaline increases HR and decreases BP (via $\beta_2$ vasodilation). * **Drug of Choice:** NE is the first-line vasopressor for **Septic Shock**.

Question 378: What drug blocks the heart rate effect of a slow intravenous infusion of phenylephrine?

A. Atenolol
B. Prazosin
C. Atropine (Correct Answer)
D. Propranolol

Explanation: ### Explanation The correct answer is **Atropine**. To understand this, one must grasp the concept of **Reflex Bradycardia**. **1. Why Atropine is Correct:** Phenylephrine is a selective **$\alpha_1$-agonist**. When administered via slow IV infusion, it causes potent vasoconstriction, leading to a significant rise in Total Peripheral Resistance (TPR) and Mean Arterial Pressure (MAP). This rise in blood pressure stimulates the **baroreceptors** in the carotid sinus and aortic arch. The baroreceptor reflex responds by increasing **vagal (parasympathetic) tone** to the heart to lower the heart rate. This is known as reflex bradycardia. Since this slowing of the heart is mediated by the Vagus nerve releasing acetylcholine onto **M$_2$ receptors**, a muscarinic antagonist like **Atropine** will block this vagal effect, preventing the decrease in heart rate. **2. Why Other Options are Incorrect:** * **Atenolol & Propranolol (A & D):** These are $\beta$-blockers. Phenylephrine does not act on $\beta_1$ receptors to increase heart rate; the bradycardia is a reflex response, not a direct drug effect. Blocking $\beta$ receptors would not prevent a vagally-mediated reflex; in fact, $\beta$-blockers might worsen bradycardia. * **Prazosin (B):** This is an $\alpha_1$-blocker. While Prazosin would block the initial vasoconstriction (and thus prevent the reflex from starting), the question asks what blocks the *heart rate effect* (the bradycardia) specifically. Atropine is the classic pharmacological tool used to demonstrate that this bradycardia is vagally mediated. **3. NEET-PG High-Yield Pearls:** * **Pure $\alpha$-agonists** (Phenylephrine, Methoxamine) cause a rise in BP and a **decrease** in HR (Reflex). * **Pure $\beta$-agonists** (Isoproterenol) cause a fall in BP and an **increase** in HR (Direct + Reflex). * **Norepinephrine** (acts on $\alpha_1, \alpha_2, \beta_1$) causes vasoconstriction and reflex bradycardia. The reflex vagal effect often overrides the direct $\beta_1$ stimulatory effect on the SA node. * **Rule of Thumb:** If a drug increases MAP significantly, the baroreceptor reflex will always attempt to decrease the HR via the Vagus nerve.

Question 379: A 65-year-old farmer presents with sweating, hypothermia, and a pulse rate of <50/min. What is the appropriate treatment?

A. Physostigmine
B. Neostigmine
C. Atropine (Correct Answer)
D. Pilocarpine

Explanation: ### **Explanation** **Correct Answer: C. Atropine** **Reasoning:** The patient presents with classic signs of **Cholinergic Crisis** (likely due to Organophosphate or Carbamate poisoning, common in farmers). The symptoms—**sweating** (diaphoresis), **hypothermia**, and **bradycardia** (pulse <50/min)—indicate overstimulation of muscarinic receptors by excess Acetylcholine (ACh). **Atropine** is the drug of choice because it is a **competitive muscarinic antagonist**. It crosses the blood-brain barrier and blocks the effects of excess ACh at the heart (reversing bradycardia), exocrine glands (stopping sweating/secretions), and smooth muscles. In organophosphate poisoning, Atropine is titrated until "Atropinization" (clearing of lung secretions and heart rate >80 bpm) is achieved. **Why other options are incorrect:** * **Physostigmine & Neostigmine (Options A & B):** These are Acetylcholinesterase (AChE) inhibitors. They prevent the breakdown of ACh, which would **worsen** the cholinergic crisis and potentially lead to fatal respiratory failure or cardiac arrest. * **Pilocarpine (Option D):** This is a direct-acting muscarinic agonist. Administering it would further stimulate the receptors, exacerbating the bradycardia and secretions. --- ### **NEET-PG High-Yield Pearls** * **Farmer + Pinpoint Pupil + Secretions =** Think Organophosphate Poisoning (OPP). * **Atropine** reverses muscarinic symptoms but **NOT** nicotinic symptoms (like muscle fasciculations). * **Pralidoxime (PAM)** is used to "reactivate" the AChE enzyme but must be given before "enzyme aging" occurs. * **Physostigmine** is the specific antidote for **Atropine poisoning** (Anticholinergic toxicity) because it crosses the BBB, unlike Neostigmine. * **Hypothermia** in OPP is often due to excessive sweating and depression of the central thermoregulatory center.

Question 380: A 35-year-old man is found unconscious. Examination reveals bilateral constricted pupils, bradycardia, excessive sweating, and secretions. What is the most likely cause?

A. Opium poisoning
B. Acute alcohol intoxication
C. Organophosphorus poisoning (Correct Answer)
D. Pontine haemorrhage

Explanation: **Explanation:** The clinical presentation of **bilateral constricted pupils (miosis), bradycardia, excessive sweating (diaphoresis), and increased secretions** (salivation, lacrimation) points toward a state of **cholinergic excess**. **1. Why Organophosphorus (OP) Poisoning is correct:** OP compounds irreversibly inhibit the enzyme **Acetylcholinesterase (AChE)**. This leads to the accumulation of Acetylcholine (ACh) at both muscarinic and nicotinic receptors. The symptoms described are classic muscarinic effects (DUMBELS: Diarrhea, Urination, Miosis, Bradycardia, Emesis, Lacrimation, Salivation/Sweating). Excessive secretions and miosis are hallmark signs that differentiate OP poisoning from other causes of unconsciousness. **2. Why other options are incorrect:** * **Opium Poisoning:** While it causes "pinpoint pupils" and respiratory depression, it typically causes **dry skin and decreased secretions**, unlike the "wet" presentation of OP poisoning. * **Acute Alcohol Intoxication:** Usually presents with **dilated pupils** (in severe cases), ataxia, and slurred speech, but not excessive cholinergic secretions or bradycardia. * **Pontine Haemorrhage:** This also presents with **pinpoint pupils** (due to sympathetic pathway disruption) and coma, but it lacks the systemic cholinergic signs like excessive sweating, salivation, and bradycardia. **3. High-Yield Clinical Pearls for NEET-PG:** * **Management:** The specific antidote is **Atropine** (reverses muscarinic signs; titrated until secretions dry up) and **Pralidoxime (2-PAM)** (cholinesterase regenerator; effective only if given before "aging" of the enzyme). * **Diagnosis:** Confirmed by measuring **low levels of Plasma/Erythrocyte Cholinesterase**. * **Death in OP Poisoning:** Usually occurs due to **respiratory failure** (bronchoconstriction + excessive secretions + neuromuscular blockade).

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free